Baidu Ventures has helped close a $31m series A round for Harvard-founded Sherlock Biosciences just over a month after the spinout launched with an initial $17.5m tranche.

Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.

Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.

Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.

Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.

The first cohort of TechNovum will feature five-to-eight inventors from the institute whose concepts have been sanctioned by its tech transfer office’s 12-week validation process.

Four businesses have collected $37,000 in equity funding each from a micro-VC fund established by University of Waterloo’s Velocity unit in support of the Velocity Fund Finals competition.

University of Washington cancer diagnostics spinout Bellwether Bio has been acquired by Guardant Health, which plans to integrate the former's expertise to advance its own pipeline.

Allianz has provided all the capital for AV8 Ventures' first fund, the VC firm being led by former executives at IBM Ventures and Qualcomm Ventures.

Deerfield Management has added yet another commercialisation fund to its roster, this time partnering University of Illinois at Chicago for a $65m vehicle.